A unique model
IRIC, located in the heart of the Université de Montréal campus, operates according to a unique model in Canada that combines, under one roof, fundamental research activities, a university-level training program and a research maturation team. These generate discoveries that advance knowledge or that can quickly translate into new therapeutic solutions.
-
![]()
News Nearly $2 million in funding for the acquisition of state-of-the-art equipment at IRIC
The Canada Foundation for Innovation (CFI) recently announced the results of its John R. Evans Leaders Fund competition. This program enables universities to attract and retain world-class researchers in Canada by providing them with state-of-the-art infrastructure. The CFI’s funding is supplemented by the Government of Quebec and other partners. Two IRIC projects have been awarded grants through this program.
-
![]()
News The Natural Sciences and Engineering Research Council of Canada Funds Two IRIC Projects
The Natural Sciences and Engineering Research Council of Canada (NSERC) recently awarded its 2026 Discovery Grants. This program aims to support ongoing research programs with long-term goals. Two IRIC projects have been awarded these grants.
-
![]()
News The Canadian Institutes of Health Research Funds Two Projects from Guy Sauvageau’s Laboratory
The Canadian Institutes of Health Research (CIHR) recently awarded grants for the Project program as part of the Spring 2026 competition. Two projects from IRIC’s Molecular Genetics of Stem Cells Research Unit, led by Guy Sauvageau, received funding.
-
![]()
News Delphine Bouilly appointed to a Courtois Chair
Delphine Bouilly, director of IRIC’s Research Unit on the Design and Application of Electronic Nanobiosensors, has been appointed to a Courtois Research Chair worth $100,000 per year for seven years.
-
![]()
News Ribosomal Dysfunction as an Oncogenic Driver in Certain Leukemias
The team led by Guy Sauvageau, director of IRIC’s Molecular Genetics of Stem Cells Research Unit, has identified a subtype of acute myeloid leukemia (AML) characterized by a significant reduction in the cells’ ability to produce proteins resulting from the loss of several ribosomal genes. This study, which proposes a new conceptual model of leukemogenesis, paves the way for the identification of new biomarkers and a new therapeutic vulnerability. Led by Principal Research Advisor Jean-François Spinella, this work is published in the journal Science Advances.
-
![]()
News The winners of the 2026 IRIC Next Generation Competition are joining the Institute!
This summer, 12 students have the opportunity to complete a 12- or 16-week research internship at IRIC, in addition to receiving an excellence scholarship.
Latest publications
See all publications-
July 31, 2026 The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.
Goyette MA, Duhamel S, Aubert L, Pelletier A, Savage P, Thibault MP, Johnson RM, Carmeliet P, Basik M, Gaboury L, Muller WJ, Park M, Roux PP, Gratton JP, Côté JF
Cell Rep 2026-07-31 ;45( 8 ):117807 - See all publications